Aminian Ali, Shoar Saeed, Khorgami Zhamak, Augustin Toms, Schauer Philip R, Brethauer Stacy A
Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH.
Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH.
Surg Obes Relat Dis. 2015 Mar-Apr;11(2):386-91. doi: 10.1016/j.soard.2014.08.018. Epub 2014 Sep 20.
The conversion rate of laparoscopic adjustable gastric banding (LAGB) to laparoscopic sleeve gastrectomy (LSG) has increased during recent years. The safety profile of one-step conversion of LAGB to LSG is not clear from the current literature.
Using the database of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), morbidly obese patients undergoing primary LSG and conversion of LAGB to LSG in one-step between 2010 and 2012 were identified. Perioperative outcomes (including 30-day composite rate comprised of 18 postoperative adverse events) were compared between groups using a univariate cross-sectional analysis.
Data of 11,320 patients (10,997 primary LSG and 323 LAGB to LSG) were analyzed. The LAGB-to-LSG group had better preoperative health status, including significantly lower body mass index, American Society of Anesthesiologists scores, and prevalence of diabetes and hypertension. Operative time for the LAGB-to-LSG group (130.0±53.7 min) was significantly longer than primary LSG group (98.5±42.8 min, P<.001). The 30-day composite adverse event rate was 6.8% in the LAGB-to-LSG group and 5.4% in the primary LSG group (P = .29). The rate of minor complications, including urinary tract infection and wound infection were significantly higher in the revisional surgery group. Thirty-day rates of other postoperative complications, reoperation, readmission, mortality, and length of hospital stay were comparable between the 2 groups.
This national data suggests that conversion of LAGB to LSG in a single stage has comparable safety to primary LSG. In this study, improved preoperative health status of patients in the revisional group may serve as an equalizer with regards to postoperative outcomes of conversion to LSG.
近年来,腹腔镜可调节胃束带术(LAGB)转换为腹腔镜袖状胃切除术(LSG)的转化率有所上升。目前的文献中尚不清楚LAGB一步转换为LSG的安全性。
利用美国外科医师学会国家外科质量改进计划(ACS-NSQIP)数据库,确定2010年至2012年间接受初次LSG以及LAGB一步转换为LSG的病态肥胖患者。采用单变量横断面分析比较两组患者的围手术期结局(包括由18种术后不良事件组成的30天综合发生率)。
分析了11320例患者的数据(10997例初次LSG和323例LAGB转换为LSG)。LAGB转换为LSG组患者术前健康状况较好,包括体重指数、美国麻醉医师协会评分以及糖尿病和高血压患病率显著更低。LAGB转换为LSG组的手术时间(130.0±53.7分钟)显著长于初次LSG组(98.5±42.8分钟,P<0.001)。LAGB转换为LSG组的30天综合不良事件发生率为6.8%,初次LSG组为5.4%(P = 0.29)。再次手术组的轻微并发症发生率,包括尿路感染和伤口感染率显著更高。两组之间其他术后并发症、再次手术、再次入院、死亡率和住院时间的30天发生率相当。
这项全国性数据表明,LAGB单阶段转换为LSG与初次LSG具有相当的安全性。在本研究中,再次手术组患者术前健康状况的改善可能是转换为LSG术后结局的一个平衡因素。